Propofol post-conditioning protects against cardiomyocyte apoptosis in hypoxia/reoxygenation injury by suppressing nuclear factor-kappa B translocation via extracellular signalregulated kinase mitogen-activated protein kinase pathway

European Journal of Anaesthesiology

Volumn 28, Issue 7, 2011, Pages 525-534

  Li, Hao ^a   Tan, Jian ^b   Zou, Zui ^a   Huang, Cai Guo ^c   Shi, Xue Yin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Anaesthetics; Cardioprotection; Ischaemic post conditioning; Myocardial ischaemia

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROPOFOL; REACTIVE OXYGEN METABOLITE; SYNAPTOTAGMIN I;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; FLOW CYTOMETRY; HEART MUSCLE CELL; HEART PROTECTION; HYPOXIA; IMMUNOFLUORESCENCE; MOLECULAR MECHANICS; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; REOXYGENATION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANALYSIS OF VARIANCE; ANESTHETICS, INTRAVENOUS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; ENZYME ACTIVATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; NF-KAPPA B; PHOSPHORYLATION; PROPOFOL; PROTEIN KINASE INHIBITORS; RATS; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 80052782921     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32834296d5     Document Type: Article

References (32)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-1136. (Pubitemid 17174962)
2. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285:H579-H588. (Pubitemid 36885888)
3. Vinten-Johansen J, Zhao ZQ, Jiang R, Zatta AJ. Myocardial protection in reperfusion with postconditioning. Expert Rev Cardiovasc Ther 2005; 3:1035-1045. (Pubitemid 41748371)
4. Bopassa JC, Ferrera R, Gateau-Roesch O, et al. PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res 2006; 69:178-185. (Pubitemid 41814821)
5. Darling CE, Jiang R, Maynard M, et al. Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. Am J Physiol Heart Circ Physiol 2005; 289:H1618-H1626. (Pubitemid 41369005)
6. Yang XM, Krieg T, Cui L, et al. NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J Mol Cell Cardiol 2004; 36:411-421. (Pubitemid 38316946)
7. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM. Postconditioning: a form of 'modified reperfusion' protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 2004; 95:230-232. (Pubitemid 39056282)
8. Hausenloy DJ, Yellon DM. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev 2007; 12:217-234. (Pubitemid 350176695)
9. Wang HY, Wang GL, Yu YH, Wang Y. The role of phosphoinositide-3-kinase/ Akt pathway in propofol-induced postconditioning against focal cerebral ischemia-reperfusion injury in rats. Brain Res 2009; 1297:177-184.
10. He W, Zhang FJ, Wang SP, et al. Postconditioning of sevoflurane and propofol is associated with mitochondrial permeability transition pore. J Zhejiang Univ Sci B 2008; 9:100-108. (Pubitemid 351234295)
11. Maeng YS, Min JK, Kim JH, et al. ERK is an anti-inflammatory signal that suppresses expression of NF-kappaB-dependent inflammatory genes by inhibiting IKK activity in endothelial cells. Cell Signal 2006; 18:994-1005.
12. Chun KS, Keum YS, Han SS, et al. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis 2003; 24:1515-1524. (Pubitemid 37160842)
13. Short TG, Aun CS, Tan P, et al. A prospective evaluation of pharmacokinetic model controlled infusion of propofol in paediatric patients. Br J Anaesth 1994; 72:302-306. (Pubitemid 24089740)
14. Servin F, Desmonts JM, Haberer JP, et al. Pharmacokinetics and protein binding of propofol in patients with cirrhosis. Anesthesiology 1988; 69:887-891. (Pubitemid 19021635)
15. Murphy PG, Bennett JR, Myers DS, et al. The effect of propofol anaesthesia on free radical-induced lipid peroxidation in rat liver microsomes. Eur J Anaesthesiol 1993; 10:261-266. (Pubitemid 23206357)
16. Tao X, Lu LQ, Xu Q, et al. Cardioprotective effects of anesthetic preconditioning in rats with ischemia-reperfusion injury: propofol versus isoflurane. J Zhejiang Univ Sci B 2009; 10:740-747.
17. Corcoran TB, Engel A, Sakamoto H, et al. The effects of propofol on neutrophil function, lipid peroxidation and inflammatory response during elective coronary artery bypass grafting in patients with impaired ventricular function. Br J Anaesth 2006; 97:825-831. (Pubitemid 44823668)
18. Javadov SA, Lim KH, Kerr PM, et al. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 2000; 45:360-369. (Pubitemid 30069501)
19. Tanaka S, Kanaya N, Homma Y, et al. Propofol increases pulmonary artery smooth muscle myofilament calcium sensitivity: role of protein kinase C. Anesthesiology 2002; 97:1557-1566. (Pubitemid 35417457)
20. Wickley PJ, Shiga T, Murray PA, Damron DS. Propofol decreases myofilament Ca2+ sensitivity via a protein kinase C-, nitric oxide synthase-dependent pathway in diabetic cardiomyocytes. Anesthesiology 2006; 104:978-987.
21. Duranteau J, Chandel NS, Kulisz A, et al. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 1998; 273:11619-11624. (Pubitemid 28272061)
22. Kevin LG, Camara AK, Riess ML, et al. Ischemic preconditioning alters realtime measure of O2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2003; 284:H566-H574. (Pubitemid 36142884)
23. Duilio C, Ambrosio G, Kuppusamy P, et al. Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol Heart Circ Physiol 2001; 280:H2649-H2657.
24. Sun HY, Wang NP, Kerendi F, et al. Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload. Am J Physiol Heart Circ Physiol 2005; 288:H1900-H1908. (Pubitemid 40418019)
25. Yang XM, Proctor JB, Cui L, et al. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 2004; 44:1103-1110. (Pubitemid 39165147)
26. Yang XM, Philipp S, Downey JM, Cohen MV. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol 2005; 100:57-63. (Pubitemid 40069107)
27. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 2004; 61:448-460. (Pubitemid 38210151)
28. Peus D, Vasa RA, Beyerle A, et al. UVB activates ERK1/2 and p38 signaling pathways via reactive oxygen species in cultured keratinocytes. J Invest Dermatol 1999; 112:751-756. (Pubitemid 29220718)
29. Zhang J, Jin N, Liu Y, Rhoades RA. Hydrogen peroxide stimulates extracellular signal-regulated protein kinases in pulmonary arterial smooth muscle cells. Am J Respir Cell Mol Biol 1998; 19:324-332. (Pubitemid 128354197)
30. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000; 20:2175-2183.
31. Zhang L, Ma Y, Zhang J, et al. A new cellular signaling mechanism for angiotensin II activation of NF-kappaB: an IkappaB-independent, RSK-mediated phosphorylation of p65. Arterioscler Thromb Vasc Biol 2005; 25:1148-1153. (Pubitemid 40776601)
32. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14:649-683. (Pubitemid 26130197)